Shares of Elan Corp (NYSE: ELN) continue to power ahead (+15%) on speculation its pulled MS drug Tysabri could ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE